OBJECTIVE: An interaction effect for developing rheumatoid arthritis (RA) was previously observed between HLA-DRB1 shared epitope (SE) alleles and smoking. We aimed to further investigate this interaction between distinct SE alleles and smoking regarding the risk of developing RA with and without anti-citrullinated protein antibodies (ACPAs). METHODS: We used data regarding smoking habits and HLA-DRB1 genotypes from 1,319 patients and 943 controls from the Epidemiological Investigation of Rheumatoid Arthritis, in which 972 patients and 488 controls were SE positive. Subsequently, 759 patients and 328 controls were subtyped for specific alleles within the DRB1*04 group. Odds ratios with 95% confidence intervals (95% CIs) were calculated by means of logistic regression. Interaction was evaluated by calculating attributable proportion due to interaction, with 95% CIs. RESULTS: A strong interaction between smoking and SE alleles in the development of ACPA-positive RA was observed for all DRB1*04 SE alleles taken as a group (relative risk [RR] 8.7 [95% CI 5.7-13.1]) and for the *0401 and *0404 alleles (RR 8.9 [95% CI 5.8-13.5]) and the *01 and *10 alleles (RR 4.9 [95% CI 3.0-7.8]) as specific, separate groups, with similar strength of interaction for the different groups (attributable proportion due to interaction 0.4 [95% CI 0.2-0.6], 0.5 [95% CI 0.3-0.7], and 0.6 [95% CI 0.4-0.8], respectively). CONCLUSION: There is a statistically significant interaction between distinct DRB1 SE alleles and smoking in the development of ACPA-positive RA. Interaction occurs with the *04 group as well as the *01/*10 group, demonstrating that regardless of fine specificity, all SE alleles strongly interact with smoking in conferring an increased risk of ACPA-positive RA.
OBJECTIVE: An interaction effect for developing rheumatoid arthritis (RA) was previously observed between HLA-DRB1 shared epitope (SE) alleles and smoking. We aimed to further investigate this interaction between distinct SE alleles and smoking regarding the risk of developing RA with and without anti-citrullinated protein antibodies (ACPAs). METHODS: We used data regarding smoking habits and HLA-DRB1 genotypes from 1,319 patients and 943 controls from the Epidemiological Investigation of Rheumatoid Arthritis, in which 972 patients and 488 controls were SE positive. Subsequently, 759 patients and 328 controls were subtyped for specific alleles within the DRB1*04 group. Odds ratios with 95% confidence intervals (95% CIs) were calculated by means of logistic regression. Interaction was evaluated by calculating attributable proportion due to interaction, with 95% CIs. RESULTS: A strong interaction between smoking and SE alleles in the development of ACPA-positive RA was observed for all DRB1*04 SE alleles taken as a group (relative risk [RR] 8.7 [95% CI 5.7-13.1]) and for the *0401 and *0404 alleles (RR 8.9 [95% CI 5.8-13.5]) and the *01 and *10 alleles (RR 4.9 [95% CI 3.0-7.8]) as specific, separate groups, with similar strength of interaction for the different groups (attributable proportion due to interaction 0.4 [95% CI 0.2-0.6], 0.5 [95% CI 0.3-0.7], and 0.6 [95% CI 0.4-0.8], respectively). CONCLUSION: There is a statistically significant interaction between distinct DRB1 SE alleles and smoking in the development of ACPA-positive RA. Interaction occurs with the *04 group as well as the *01/*10 group, demonstrating that regardless of fine specificity, all SE alleles strongly interact with smoking in conferring an increased risk of ACPA-positive RA.
Authors: Lars Klareskog; Patrik Stolt; Karin Lundberg; Henrik Källberg; Camilla Bengtsson; Johan Grunewald; Johan Rönnelid; Helena Erlandsson Harris; Ann-Kristin Ulfgren; Solbritt Rantapää-Dahlqvist; Anders Eklund; Leonid Padyukov; Lars Alfredsson Journal: Arthritis Rheum Date: 2006-01
Authors: S P Linn-Rasker; A H M van der Helm-van Mil; F A van Gaalen; M Kloppenburg; R R P de Vries; S le Cessie; F C Breedveld; R E M Toes; T W J Huizinga Journal: Ann Rheum Dis Date: 2005-07-13 Impact factor: 19.103
Authors: Tom W J Huizinga; Christopher I Amos; Annette H M van der Helm-van Mil; Wei Chen; Floris A van Gaalen; Damini Jawaheer; Geziena M T Schreuder; Mark Wener; Ferdinand C Breedveld; Naila Ahmad; Raymond F Lum; Rene R P de Vries; Peter K Gregersen; Rene E M Toes; Lindsey A Criswell Journal: Arthritis Rheum Date: 2005-11
Authors: Annette H M van der Helm-van Mil; Kirsten N Verpoort; Saskia le Cessie; Tom W J Huizinga; René R P de Vries; René E M Toes Journal: Arthritis Rheum Date: 2007-02
Authors: Robert M Plenge; Leonid Padyukov; Elaine F Remmers; Shaun Purcell; Annette T Lee; Elizabeth W Karlson; Frederick Wolfe; Daniel L Kastner; Lars Alfredsson; David Altshuler; Peter K Gregersen; Lars Klareskog; John D Rioux Journal: Am J Hum Genet Date: 2005-11-01 Impact factor: 11.025
Authors: Elaine F Remmers; Robert M Plenge; Annette T Lee; Robert R Graham; Geoffrey Hom; Timothy W Behrens; Paul I W de Bakker; Julie M Le; Hye-Soon Lee; Franak Batliwalla; Wentian Li; Seth L Masters; Matthew G Booty; John P Carulli; Leonid Padyukov; Lars Alfredsson; Lars Klareskog; Wei V Chen; Christopher I Amos; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Peter K Gregersen Journal: N Engl J Med Date: 2007-09-06 Impact factor: 91.245
Authors: Hye-Soon Lee; Patricia Irigoyen; Marlena Kern; Annette Lee; Franak Batliwalla; Houman Khalili; Frederick Wolfe; Raymond F Lum; Elena Massarotti; Michael Weisman; Claire Bombardier; Elizabeth W Karlson; Lindsey A Criswell; Robert Vlietinck; Peter K Gregersen Journal: Arthritis Rheum Date: 2007-06
Authors: Qi-Quan Huang; Renee E Koessler; Robert Birkett; Andrea Dorfleutner; Harris Perlman; G Kenneth Haines; Christian Stehlik; Christopher V Nicchitta; Richard M Pope Journal: Arthritis Rheum Date: 2012-11
Authors: Christoph Kessel; Kutty S Nandakumar; Francis B Peters; Varun Gauba; Peter G Schultz; Rikard Holmdahl Journal: Arthritis Rheumatol Date: 2014-03 Impact factor: 10.995